GSK opens first high-potency facility in Singapore to produce …
WEBNov 17, 2022 · SINGAPORE - GSK officially opened its first high-potency manufacturing and test facility in Singapore on Thursday, with the capability to manufacture highly potent components for cancer...
WEBGSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments. S$44m investment in the new high potency manufacturing facility and laboratory further strengthens Jurong …
GSK debuts new $33M high-potency Singapore plant focused on …
WEBNov 17, 2022 · The facility is located in Jurong, Singapore, and will make a cytotoxic component for antibody-drug conjugates to treat cancer, the company said in a Nov. 17 press release.
GSK opens first-in-Singapore high potency manufacturing and …
WEBNov 17, 2022 · GSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments. GSK plc today announced the opening of a new, S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore.
GSK Opens First-In-Singapore High Potency Manufacturing And …
WEBNov 17, 2022 · GSK plc today announced the opening of a new, S$44M high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore.
Singapore - GSK
WEBGSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments GSK announced the opening of a S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore.
Speech by Minister Gan Kim Yong, Guest-of-Honour at GSK’s …
WEBJul 13, 2023 · GSK continues to be a valuable contributor to Singapore’s biopharmaceutical industry 10. Today, we are here to celebrate yet another milestone in our long-standing partnership – the expansion of GSK’s Tuas Vaccine Facility.
GSK Opens First High-Potency Facility in Singapore for Cancer …
WEBBritish multinational pharmaceutical and biotechnology company GlaxoSmithKline (GSK) has announced the opening of a new SGD 44 million (USD 33 million) high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore.
GSK opens $95M continuous production operation in Singapore
WEBJul 8, 2019 · GSK says it built two continuous manufacturing facilities and expanded another facility with its S$130 million ($95) investment. The first new drug to be manufactured with the enzymatic process...
WEBThe first in Singapore capable of producing highly potent cytotoxic ingredients in ADCs, for breakthrough immunotherapy cancer treatments. The global biopharma company GSK plc has launched a new, S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore.The event also marked 40 years since the ...